AbbVie’s experimental drug to treat early Parkinson’s disease helped significantly improve patients’ ability to carry out daily tasks such as eating and walking, months…
Reuters Health Information
AbbVie’s Parkinson’s Disease Drug Improves Patient Mobility in Late-stage Study
